EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotype, Ethnicity, and Drug–Drug Interaction Modeling as Means of Verifying Transporter Biomarker PBPK Model: The Coproporphyrin‐I Story

Yuki Ujihira iD, Shawn Pei Feng Tan iD, Daniel Scotcher iD, Aleksandra Galetin iD

CPT: Pharmacometrics & Systems Pharmacology · 2025

DOI: 10.1002/psp4.70008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2025. Verfasst von Yuki Ujihira und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Coproporphyrins, Liver-Specific Organic Anion Transporter 1, Models, Biological. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coproporphyrin‐I (CP‐I) is a selective endogenous biomarker of organic anion‐transporting polypeptide (OATP)1B. Multiple CP‐I PBPK models with differing input parameters have been reported so far. This study proposed a harmonized CP‐I PBPK model and evaluated its ability to predict the effect of ethnicity, SLCO1B1 genotype c.521T>C, and sex on CP‐I baseline and CP‐I‐drug interactions using the largest clinical dataset to date. The CP‐I PBPK model successfully predicted CP‐I plasma baseline from 731 subjects, with 97% of predictions within 1.5‐fold of the observed data. Prediction of weak, moderate, and strong OATP1B‐mediated interactions with probenecid, low‐dose cyclosporine, and rifampicin, respectively, was evaluated with 21 datasets. Overall, > 76% of CP‐I C max R and AUCR were predicted within the Guest criterion. In vivo OATP1B K i estimated by the biomarker model was up to ninefold lower compared to in vitro values. Sensitivity analyses showed differences in estimated in vivo K i depending on the assumed contribution of non‐inhibited/parallel pathway (renal) for CP‐I (0%–15%), highlighting the need to consider this factor when using biomarker PBPK models for such purposes. Finally, the appropriate metric for monitoring CP‐I was evaluated for inhibitors with different potency and PK relative to CP‐I. In the case of strong/moderate OATP1B inhibitors with short t 1/2 , C max R was the most sensitive metric for monitoring CP‐I OATP1B interactions, whereas both C max R and AUCR were applicable for inhibitors with long t 1/2 . The current study provides a harmonized CP‐I PBPK model, together with recommendations to support the optimal design of prospective clinical trials for the assessment of OATP1B‐mediated DDIs using this biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoproporphyrinsLiver-Specific Organic Anion Transporter 1Models, BiologicalHumansDrug InteractionsMaleFemaleGenotypeRifampinBiomarkersAdultCyclosporineProbenecidMiddle AgedYoung AdultEthnicity

Stichwörter der Autor:innen

PBPKbiomarkerdrug–drug interactiontransporter

Substanzen

Coproporphyrinscoproporphyrin ILiver-Specific Organic Anion Transporter 1SLCO1B1 protein, humanRifampinBiomarkersCyclosporineProbenecid

Autor:innen und Institutionen

  • Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK.
  • Laboratory for Safety Assessment and ADME, Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, Shizuoka, Japan.

ORCID-Profile: Yuki Ujihira, Shawn Pei Feng Tan, Daniel Scotcher, Aleksandra Galetin

Zitieren

APA

Ujihira, Y., Tan, S. P. F., Scotcher, D., & Galetin, A. (2025). Genotype, Ethnicity, and Drug–Drug Interaction Modeling as Means of Verifying Transporter Biomarker PBPK Model: The Coproporphyrin‐I Story. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70008

Vancouver

Ujihira Y, Tan SPF, Scotcher D, Galetin A. Genotype, Ethnicity, and Drug–Drug Interaction Modeling as Means of Verifying Transporter Biomarker PBPK Model: The Coproporphyrin‐I Story. CPT: Pharmacometrics & Systems Pharmacology. 2025. doi:10.1002/psp4.70008

BibTeX
@article{Ujihira2025,
  author = {Ujihira, Yuki and Tan, Shawn Pei Feng and Scotcher, Daniel and Galetin, Aleksandra},
  title = {Genotype, Ethnicity, and Drug–Drug Interaction Modeling as Means of Verifying Transporter Biomarker PBPK Model: The Coproporphyrin‐I Story},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2025},
  doi = {10.1002/psp4.70008}
}
Kostenlos starten →